Future studies should utilize high-throughputgenotyping methods such as next generation sequencing to account for loss ofheterozygosity in CDKN2A and PTEN, examine therole of T in proliferation, and search for mutations outside ofknown hotspots in cancer genes. The gene discussed is CDKN2A; the disease is cancer.